Literature DB >> 15718062

Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project.

Erol Digiusto1, Nicholas Lintzeris, Courtney Breen, Jo Kimber, Richard P Mattick, James Bell, Robert Ali, John B Saunders.   

Abstract

This study included 380 participants in five heroin detoxification trials whose data were pooled to enable direct comparison of five detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Rapid detoxification achieved similar initial abstinence rates with either anaesthesia or sedation (average 59%), which were higher than was achieved by inpatient detoxification using clonidine plus other symptomatic medications (24%), which in turn was higher than outpatient detoxification using either buprenorphine (12%) or clonidine plus other symptomatic medications (4%). Older participants and those using more illicit drugs were more likely to achieve abstinence. Entry rates into ongoing postdetoxification treatment were as follows: buprenorphine outpatient (65%), sedation (63%), anaesthesia (42%), symptomatic outpatient (27%), and symptomatic inpatient (12%). Postdetoxification treatment with buprenorphine or methadone was preferred over naltrexone. Participants with more previous detoxification attempts were more likely to enter postdetoxification treatment. Given that outpatient detoxification was more effective with buprenorphine than with symptomatic medications and that rapid detoxification was more effective than the symptomatic inpatient method, the roles of the symptomatic methods should be reconsidered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718062     DOI: 10.1016/j.addbeh.2004.06.002

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  5 in total

1.  Early outcomes following low dose naltrexone enhancement of opioid detoxification.

Authors:  Paolo Mannelli; Ashwin A Patkar; Kathleen Peindl; Edward Gottheil; Li-Tzy Wu; David A Gorelick
Journal:  Am J Addict       Date:  2009 Mar-Apr

2.  Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid-dependents.

Authors:  Hassan Ziaaddini; Mansooreh Nasirian; Nouzar Nakhaee
Journal:  Addict Health       Date:  2012 Summer-Autumn

3.  Brief vs. extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomes.

Authors:  Elizabeth C Katz; Robert P Schwartz; Stuart King; David A Highfield; Kevin E O'Grady; Timothy Billings; Devang Gandhi; Eric Weintraub; David Glovinsky; Wardell Barksdale; Barry S Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

4.  Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men.

Authors:  Hassan Ziaaddini; Shima Heshmati; Maryam Chegeni; Mahboobeh Mousavi-Ramezanzade; Shahrzad Mazhari
Journal:  Addict Health       Date:  2018-10

5.  A comparison of the efficacy of buprenorphine and clonidine in detoxification of heroin-dependents and the following maintenance treatment.

Authors:  Hassan Ziaaddini; Mansooreh Nasirian; Nouzar Nakhaee
Journal:  Addict Health       Date:  2010 Winter-Spring
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.